• Allford, S.L., Harrison, P., Lawrie, A.S., Liesner, R., Mackie, I.J. & Machin, S.J. (2000) Von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura. British Journal of Haematology, 111, 12151222.
  • Asada, Y., Sumiyoshi, A., Hayashi, T., Suzumiya, J. & Kaketani, K. (1985) Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thrombosis Research, 38, 469479
  • Evans, G., Llewelyn, C., Luddington, R., Baglin, T.P. & Williamson, L.M. (1999) Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clinical and Laboratory Haematology, 21, 119123.
  • Fijnheer, R., Paijmans, B., Verdonck, L.F., Nieuwenhuis, H.K., Roest, M. & Dekker, A.W. (2002) Factor V Leiden in central venous catheter-associated thrombosis. British Journal of Haematology, 118, 267270.
  • Flamholz, R., Jeon, H.R., Baron, J.M. & Baron, B.W. (2000) Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses? Journal of Clinical Apheresis, 15, 169172.
  • Harrison, C.N., Lawrie, A.S., Iqbal, A., Hunter, A. & Machin, S.J. (1996) Plasma exchange with solvent/detergent-treated plasma of resistant thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 756758.
  • Haubelt, H., Blome, M., Kiessling, A.H., Isgro, F., Bach, J., Saggau, W. & Hellstern, P. (2002) Effects of solvent/detergent-treated plasma and fresh-frozen plasma on haemostasis and fibrinolysis in complex coagulopathy following open-heart surgery. Vox Sanguinis, 82, 914.
  • Horowitz, B., Bonomo, R., Prince, A.M., Chin, S.N., Brotman, B. & Shulman, R.W. (1992) Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood, 79, 826831.
  • Hsu, H.W., Belfort, M.A., Vernino, S., Moake, J.L. & Moise, Jr, K.J. (1995) Postpartum thrombotic thrombocytopenic purpura complicated by Budd–Chiari syndrome. Obstetrics and Gynecology, 85, 839843.
  • Leebeek, F.W., Schipperus, M.R. & Van Vliet, H.H. (1999) Coagulation factor levels in solvent/detergent-treated plasma. Trans-fusion, 39, 11501151.
  • Moake, J.L. (1995) Thrombotic thrombocytopenic purpura. Thrombosis and Haemostasis, 74, 240245.
  • Moake, J., Chintagumpala, M., Turner, N., McPherson, P., Nolasco, L., Steuber, C., Santiago-Borrero, P., Horowitz, M. & Pehta, J. (1994) Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood, 84, 490497.
  • Pamphilon, D. (2000) Viral inactivation of fresh-frozen plasma. British Journal of Haematology, 109, 680693.
  • Rizvi, M.A., Vesely, S.K., George, J.N., Chandler, L., Duvall, D., Smith, J.W. & Gilcher, R.O. (2000) Complications of plasma exchange in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura–hemolytic–uremic syndrome. Transfusion, 40, 896901.
  • Rock, G., Shumak, K.H., Sutton, D.M., Buskard, N.A. & Nair, R.C. (1996) Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group. British Journal of Haematology, 94, 383386.
  • Rock, G.A., Shumak, K.H., Buskard, N.A., Blanchette, V.S., Kelton, J.G., Nair, R.C. & Spasoff, R.A. (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. New England Journal of Medicine, 325, 393397.
  • Rodgers, A. on behalf of the Pulmonary Embolism Prevention Trial Collaborative Group (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: pulmonary embolism prevention (PEP) trial. Lancet, 355, 12951302.
  • De La Rubria, J., Arriaga, F., Linares, D., Larrea, L., Carpio, N., Marty, M.L. & Sanz, M.A. (2001) Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura. British Journal of Haematology, 114, 721723.
  • Schwartz, S.G., McPherson, A.R., Mieler, W.F., Sessoms, S.L., Moake, J.L. & Holz, E.R. (2000) Bilateral combined occlusion of the central retinal artery and vein secondary to thrombotic thrombocytopenic purpura. Archives of Ophthalmololgy, 118, 13041305.
  • Thompson, C.E., Damon, L.E., Ries, C.A. & Linker, C.A. (1992) Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood, 80, 18901895.
  • Williamson, L.M., Llewelyn, C.A., Fisher, N.C., Allain, J.P., Bellamy, M.C., Baglin, T.P., Freeman, J., Klinck, J.R., Ala, F.A., Smith, N., Neuberger, J. & Wreghitt, T.G. (1999) A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation. Trans-fusion, 39, 12271234.
  • Yarranton, H. & Machin, S.J. (2002) Thrombotic thrombocytopenic purpura: New approaches to diagnosis and management. Blood Therapies in Medicine, 2, 8291.
  • Zeigler, Z.R., Shadduck, R.K., Gryn, J.F., Rintels, P.B., George, J.N., Besa, E.C., Bodensteiner, D., Silver, B. & Kramer, R.E. (2001) Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP). Journal of Clinical Apheresis, 16, 1922.